Pretransplant Psoas Muscle Cross-Sectional Area and Postkidney Transplant Outcomes.
Pretransplant Psoas Muscle Cross-Sectional Area and Postkidney Transplant Outcomes.
复制标题
移植前腰肌横截面积和肾移植后结果。
DOI:
10.1016/j.transproceed.2022.05.035
复制
发表时间:
2022-09
影响因子:
0.9
通讯作者:
Gupta A
中科院分区:
文献类型:
--
作者:
Norris T;Montgomery R;Cibrik D;Reintjes M;Chakraborty S;Fishback S;Gupta A
Sarcopenia is associated with adverse outcomes in end stage kidney disease (ESKD). We evaluated if pre-transplant sarcopenia affects post-transplant outcomes in kidney transplant (KT) recipients. In this single center retrospective study of adult ESKD patients, we analyzed the association between pre-KT psoas muscle cross-sectional area and critical post-transplant outcomes of decline in estimated glomerular filtration rate (eGFR), graft loss, rehospitalization, and mortality using Cox proportional hazard model adjusted for age, sex, and race. Pre-KT abdomen and pelvis CT scans performed during evaluation for KT eligibility were available for 573 KT recipients. Of these, 465 KT recipients received kidney alone transplant, 71 received simultaneous liver kidney transplant (SLK), and 37 received simultaneous pancreas kidney transplant (SPK). Patients were 49±13 years old, 16% Black, and 60% men. For kidney alone transplant recipients, a higher psoas muscle cross sectional area was associated with a shorter length of hospitalization (β coefficient −0.003, 95% CI −0.005, −0.0007). Conversely, pre-KT psoas muscle cross sectional area did not predict decline in eGFR, graft loss, mortality, or early rehospitalization. For SLK recipients, psoas muscle cross sectional area did not predict any of the a priori outcomes. For SPK recipients, higher pre-transplant psoas muscle cross sectional area predicted a longer length of hospitalization (β coefficient 0.03, 95% CI 0.01, 0.05). There was no association between psoas muscle cross sectional area and other outcomes assessed. Pre-transplant psoas muscle cross sectional area is not predictive of post-transplant decline in eGFR, graft loss, rehospitalization or mortality in kidney alone, SPK, or SLK transplants.
登录
查看更多内容
影响因子:
3
作者:
Hanna, Ramy M.;Ghobry, Lena;Kalantar-Zadeh, Kamyar
通讯作者:
Kalantar-Zadeh, Kamyar
DOI:
10.1016/j.jamcollsurg.2010.03.039
发表时间:
2010-08
影响因子:
5.2
作者:
Englesbe, Michael J.;Patel, Shaun P.;He, Kevin;Lynch, Raymond J.;Schaubel, Douglas E.;Harbaugh, Calista;Holcombe, Sven A.;Wang, Stewart C.;Segev, Dorry L.;Sonnenday, Christopher J.
通讯作者:
Sonnenday, Christopher J.
DOI:
10.1016/j.clinre.2021.101692
发表时间:
2021-06-09
影响因子:
2.7
作者:
Mazzola, Alessandra;Brustia, Raffaele;Conti, Filomena
通讯作者:
Conti, Filomena
影响因子:
4.6
作者:
Fitzpatrick JA;Basty N;Cule M;Liu Y;Bell JD;Thomas EL;Whitcher B
通讯作者:
Whitcher B
影响因子:
4.4
作者:
Haak, Daniel;Page, Charles-E.;Deserno, Thomas M.
通讯作者:
Deserno, Thomas M.